CME Group CME Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.76B+3.6% | $6.52B+1.9% | $6.4B-0.7% | $6.44B+2.5% | $6.28B+2.5% | ||
| $2.33B+1.6% | $2.29B+2.3% | $2.24B+0.2% | $2.24B+1.4% | $2.2B+0.3% | ||
| $4.43B+4.8% | $4.23B+1.7% | $4.16B-1.2% | $4.21B+3.2% | $4.08B+3.8% | ||
| 65.6%+0.7pp | 64.9%-0.1pp | 65%-0.3pp | 65.3%+0.4pp | 64.9%+0.8pp | ||
| $175.3M+1.1% | $173.4M+1.8% | $170.4M+2.3% | $166.6M+2.4% | $162.7M+1.1% | ||
| $1.17B+5.8% | $1.1B+59.2% | $691.7M+8.1% | $640M+7.9% | $592.9M-2.8% | ||
| —— | —— | —— | —— | —— | ||
| $1.33B+5.4% | $1.26B+16.0% | $1.08B+0.5% | $1.08B+3.2% | $1.05B+3.0% | ||
| $4.3B+5.5% | $4.07B+8.3% | $3.76B-0.1% | $3.77B+3.9% | $3.63B+2.8% | ||
| 63.6%+1.1pp | 62.5%+3.7pp | 58.8%+0.4pp | 58.4%+0.7pp | 57.7%+0.2pp | ||
| $11.72+5.0% | $11.16+8.1% | $10.32-0.1% | $10.33+3.9% | $9.94+2.8% | ||
| $4.6B+6.0% | $4.34B+1.7% | $4.27B-1.2% | $4.32B+3.0% | $4.19B+3.6% | ||
| 68%+1.5pp | 66.5%-0.2pp | 66.7%-0.3pp | 67%+0.3pp | 66.7%+0.7pp | ||
| $4.43B+4.8% | $4.23B+1.7% | $4.16B-1.2% | $4.21B+3.2% | $4.08B+3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 7.5% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.6% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.72.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
